2023 has been one heck of a year. The S&P 500 is close to all-time highs. The Fed raised interest rates in July, as the economy is still on fire. The retirement accounts brought in a total dividend...

The biggest layoffs this summer came at Yellow Corp., CVS Health, KPMG, Biogen and Binance.

Shares of Medtronic and CVS Health offer above-average dividend yields after falling significantly in recent weeks. One of CVS Health's integrated healthcare businesses recently experienced a setba...

CVS is going to commercialize a biosimilar to Humira. Humira probably won't be the last high-earning drug it copies.

Very rarely do investors get the opportunity to consider a purchase of a high-quality asset or company at a steep discount to the overall industry it operates within. Today, there is not only one n...

CVS Health Corporation (CVS) is entering the biosimilar space with its new subsidiary brand Cordavis. Yahoo Finance Health Care Reporter Anjalee Khemlani breaks down what the brand entails and its ...

CNBC's Bertha Coombs joins 'Closing Bell Overtime' to talk news that CVS Health is launching a subsidiary to make biosimilar drugs to Humira.

CVS Health Corp. CVS, -0.97% said Wednesday that it has launched a new subsidiary that will work directly with drugmakers to co-produce and commercialize biosimilars. The subsidiary, Cordavis, has ...

CVS Health Corp said on Wednesday it has launched Cordavis, a unit that will work directly with manufacturers to commercialize and co-produce biosimilars for the U.S. market.

CVS Health is launching a new company, Cordavis, to commercialize and produce biosimilar drugs, the cheaper versions of expensive prescriptions derived from biotechnology.

CVS is looking to strengthen its foothold in the biosimilars market, which is expected to grow to $100 billion over the next six years.

Covid-19 related stocks started spiking again this week. Driven primarily by reports about new variants and increasing spread.

Yahoo Finance Health Care Reporter Anjalee Khemlani reports on Blue Shield of California dropping CVS as pharmacy benefits manager and her conversation with Blue Shield of California CEO Paul Marko...

Navigating the stock market is a journey mixed with analysis, timing, and good fortune. But for those looking at wealth accumulation, there's always the burning question: which are the stocks to bu...

Shares of retail pharmacy chain CVS Health (NYSE: CVS ) only managed modest gains during Friday's afternoon session, an unremarkable consolation following yesterday's dramatic implosion. Sparking t...